| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.31B | 23.04B | 26.81B | 24.11B | 22.80B | 24.20B |
| Gross Profit | 5.93B | 6.34B | 6.85B | 5.94B | 5.98B | 4.93B |
| EBITDA | 1.74B | 2.04B | 2.66B | 2.07B | 2.21B | 1.43B |
| Net Income | 188.00M | 559.00M | 1.42B | 921.00M | 1.11B | 337.00M |
Balance Sheet | ||||||
| Total Assets | 41.30B | 41.09B | 43.83B | 38.74B | 37.00B | 37.51B |
| Cash, Cash Equivalents and Short-Term Investments | 8.64B | 7.18B | 7.66B | 6.63B | 8.70B | 10.01B |
| Total Debt | 17.13B | 16.44B | 17.62B | 14.38B | 13.49B | 15.47B |
| Total Liabilities | 25.15B | 23.99B | 26.83B | 22.76B | 21.67B | 23.38B |
| Stockholders Equity | 15.97B | 16.92B | 16.99B | 15.98B | 15.32B | 14.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.41B | 328.00M | -2.39B | 809.00M | 2.98B |
| Operating Cash Flow | 0.00 | 2.67B | 882.00M | -1.64B | 1.11B | 3.48B |
| Investing Cash Flow | 0.00 | -1.08B | -2.18B | -742.00M | -208.00M | -540.00M |
| Financing Cash Flow | 0.00 | -2.07B | 2.25B | 272.00M | -2.30B | 548.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥697.04B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥21.27B | 16.55 | ― | 3.83% | -7.50% | 22.01% | |
74 Outperform | ¥7.38T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
74 Outperform | ¥83.69B | 12.79 | ― | 2.20% | 4.75% | 164.54% | |
70 Outperform | ¥81.90B | 10.57 | ― | 3.05% | 10.79% | 12.28% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥630.45B | 15.62 | ― | 2.57% | 4.81% | -49.43% |